Regulatory matters are usually read one at a time, which is close to the least useful way to learn from them. Each one arrives as an isolated story: a specific token, a specific founder, a specific number. Read several together, across a Massachusetts courtroom, a Panama-registered foundation, and a $16 million SAFT offering, and the differences between them start to matter less than the structure they share.
Across the matters we’ve covered this month, a federal court’s finding against Rivetz, a settled DAO structure case, a settled promoter-disclosure matter, an active complaint against Unicoin, and an early-stage complaint involving Bitcoin Latinum, the specific misconduct varies considerably: an unregistered token with no present utility, a decentralised structure hiding centralised control, undisclosed compensation for promotion, overstated asset-backing, and alleged misuse of investor funds. What doesn’t vary is the underlying pattern. In every one, investors were told something specific and falsifiable, and what was falsifiable didn’t hold.
That’s a narrower claim than “these projects failed,” and a more useful one, because it points to something concrete to test rather than a general impression to distrust. It’s also the distinction we start from in every matter we assess: a failed investment and a failed duty are not the same event, and the difference almost never turns on whether an investor lost money. It turns on whether what they were told matches what actually happened to their capital.
None of the five gaps described across these matters required unusual sophistication to eventually establish. Each required testing a specific claim against a specific record: a court’s own reasoning on what Howey requires, a settlement’s finding on who actually controlled a treasury, a wallet’s public transaction history, a bank statement showing where money actually went. That’s a fundamentally different exercise from predicting which projects will fail, which is close to impossible. It’s closer to the ordinary work of comparing a claim to a record, applied consistently, and it’s available after a loss in a way that prediction never is beforehand.
The uncomfortable part, for any investor, is that confidence and specificity aren’t reliable substitutes for truth, even though they function as one for most people, most of the time. An insurance claim, a registration claim, a decentralisation claim: each is either accurate or it isn’t, and conviction in how it’s stated has no bearing on which. Most investors will never have the time or access to test every claim in every raise they’re offered. The five matters above suggest a narrower, more practical starting point: when something has already gone wrong, the claims that felt most reassuring at the time are usually the first ones worth testing.
This piece discusses public findings and allegations across five separate regulatory matters, at different stages of resolution. Where a matter remains contested or unresolved, nothing in this piece should be read as a conclusion about guilt or liability.